events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
Search
Login
events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
Login
News and Community
Arteraai Prostate Test
,
Digital Pathology
,
Mhspc
,
Precision Medicine
,
Prostate Cancer
,
Tempus Ai
May 25, 2026
Tempus AI Unveils ArteraAI Prostate Test (mHSPC) for Metastatic Patients
Cancer Care
,
Clinical Trials
,
Data Science
,
Patient Care
,
Precision Medicine
,
Tempus
April 24, 2026
Tempus and USC Partner to Advance AI-Driven Precision Medicine Innovation
Ai Immunomodulators
,
Drug Development
,
Gen1e
,
Precision Medicine
,
Rare Diseases
,
Strategic Partnership
April 22, 2026
GEn1E and Rubicon Research Forge Strategic Alliance for AI-Powered Precision Immunomodulators Development
Active Follow-up
,
Ai-enabled
,
Clinical Safety
,
Guideline-concordant
,
Modern Oncology
,
Portal
,
Precision Medicine
,
Tempus
,
Therapy
April 14, 2026
Tempus Introduces Automated “Active Follow-Up” Service to Enhance Guideline-Concordant Patient Care
Biotech Leadership
,
Diagnostics Innovation
,
Healthcare Innovation
,
Healthcare Technology Leadership
,
Kevin Haas
,
Life Sciences Technology
,
Precision Medicine
,
Veracyte
March 18, 2026
Veracyte Appoints Kevin Haas as Chief Development and Technology Officer
Ai Lung Cancer Screening
,
Eyonis
,
Median Technologies
,
Precision Medicine
,
Precision Oncology Workflow
,
Tempus Pixel
February 13, 2026
Tempus and Median Technologies Partner on AI Lung Cancer Screening
American Academy
,
Genedx
,
Genomics
,
Katherine Stueland
,
Pediatric Diagnostics
,
Precision Medicine
,
Rare Disease
,
Time100 Health
February 12, 2026
GeneDx CEO Katherine Stueland Named to TIME100 Health 2026
Ai Foundation Models
,
Genomic Ai
,
Healthcare Ai
,
Medical Innovation
,
Natera
,
Nvidia
,
Precision Medicine
January 13, 2026
Natera Scales AI Foundation Models with NVIDIA to Advance Precision Medicine
Biotechs
,
Healthcare Technology
,
Life Sciences Companies
,
Precision Medicine
,
Tempus Total Contract Value
January 12, 2026
Tempus AI Total Contract Value (TCV) Hits Record $1.1 Billion
Load More